Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: The impact of empagliflozin on cardiac physiology and fibrosis early after myocardial infarction in non-diabetic rats

Fig. 3

Empagliflozin increases LV cavity without affecting cardiac muscle mass. a Control cardiac muscle, b Empagliflozin treated cardiac muscle. External circle (deep red) represents total heart cross sectional area, middle circle (orange) represents LV cross sectional area, inner circle (white) – LV cavity cross sectional area. N were 6 and 8 to the control and empagliflozin, respectively * P<0.05 vs. control by student's t-test. Numerical data presents mean±SD of the cross sectional areas.

Back to article page